Cofactor Genomics
Cofactor Genomics is a precision-medicine biotechnology company that applies RNA-sequencing and machine learning to build predictive immuno-oncology diagnostics. Its flagship OncoPrism assay is designed to predict which cancer patients will respond to immunotherapy, and the company runs the multi-center PREDAPT clinical trial across more than 24 healthcare systems spanning 11 solid-tumor cancers. Cofactor Genomics is a diagnostics and life-sciences company rather than an API provider; it publishes no public developer portal, API documentation, or SDKs. This profile is maintained in the API Evangelist network as a company record surfaced from venture-capital portfolios (DCVC, Menlo Ventures, Y Combinator) and enriched with identity and domain-security metadata.
Cofactor Genomics is profiled on the APIs.io network. Tagged areas include Company, Genomics, Precision Medicine, Diagnostics, and Immuno-Oncology.
Cofactor Genomics’ developer surface includes engineering blog and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API